European public procurement and grants data from official registers · Data as of 17 November 2026; updated daily.

Grant programme · United States

Arthritis, Musculoskeletal and Skin Diseases Research

Arthritis, Musculoskeletal and Skin Diseases Research (United States): the programme's calls and grants. 20 calls on the site, 7 open now; its calls usually open in November. Data as of 17 November 2026; updated daily.

Funder: National Institutes of Health (Department of Health and Human Services)

Grants in the last 24 months
0
Recipients
0
Open calls
7
Calls on the site
20

Calls usually open in November

About the programme

Objectives: The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) mission is to support research into the causes, treatment, and prevention of arthritis and musculoskeletal and skin diseases; training of basic and clinical scientists to carry out this research; and…

Read more at the source

Open calls

Earlier calls

Grant callStatusCloses
Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed) (round Dec 2024 – Nov 2026)Closed2 November 2026
Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required) (round Dec 2024 – Nov 2026)Closed2 November 2026
Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed) (round Dec 2024 – Dec 2025)Closed5 December 2025
Ancillary Studies to Ongoing Clinical Projects (R01 Clinical Trial Not Allowed) (round Dec 2024 – Dec 2025)Closed5 December 2025
Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases from Academic/Non-profit Lab to Marketplace (SBIR [R43/R44] Clinical Trial Not Allowed)Closed5 September 2025
Limited Competition: Small Grant Program for NIAMS K01, K08, K23, and K25 Recipients (R03) (Clinical Trials Not Allowed) (round Dec 2024 – Feb 2025)Closed19 February 2025
Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed) (round Nov 2023 – Dec 2024)Closed9 December 2024
NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required) (round May 2024 – Dec 2024)Closed9 December 2024
Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required) (round Nov 2023 – Dec 2024)Closed9 December 2024
Ancillary Studies to Ongoing Clinical Projects (R01 Clinical Trial Not Allowed) (round Nov 2022 – Dec 2024)Closed8 December 2024
Limited Competition: Small Grant Program for NIAMS K01, K08, K23, and K25 Recipients (R03) (Clinical Trials Not Allowed) (round Mar 2022 – Dec 2024)Closed8 December 2024
Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed) (round Nov 2022 – Dec 2024)Closed8 December 2024
Limited Competition: Promoting a Basic Understanding of Chemical Threats to Skin (R34 Clinical Trial Not Allowed)Closed7 September 2024

Grant calendars

Grants for projects that started between 17 November 2024 and 17 November 2026; amounts in euro at the Eurostat rate of each year.

Questions and answers

When does Arthritis, Musculoskeletal and Skin Diseases Research open calls?
7 open now: NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Require… (4 March 2027), Limited Competition: CCRP Initiative: Promoting a Basic Understanding of Chemical Threats… (7 January 2028), Limited Competition: Small Grant Program for Mentored Research Career Development Award R… (16 July 2029), …. Its calls usually open in November.